Experience

Paratek Pharmaceuticals

• United States
• Pharmaceutical Manufacturing
• 200 - 300 Employee

• Marketing Research & Analytics Lead

  • Feb 2016 - Present

  In preparation for the potential first commercial launch for the organization, ensure both the development of deep, actionable customer insights and incorporation of insights into organizational strategies and tactics to capitalize on areas of potential competitive advantage. Responsibilities: o Development & execution of market research plan in preparation for launch of omadacycline as well as follow-on compounds; post-launch tracking and updates to positioning and other needs o Design & execute analytics in support of marketing and sales initiatives with the goal of optimizing efficiency & ROIs, as well as better-understanding market dynamics o Development of forecasts for internal assets in support of planning needs, as well as for external assets in support of BD opportunities o Ensure up-to-the moment awareness of external developments that could potentially impact omadacycline or other internal compounds o Triangulation of data into the development of insights, and ensuring that knowledge is incorporated into, and supports, strategic imperatives Show less



Lundbeck

• Denmark
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Sr. Director & Head of Customer Insights & Portfolio Development

  • Feb 2013 - Nov 2015

  Leadership of five distinct teams (Commercial Portfolio Dev, Primary Market Res, Bus Analysis, Competitive Intel, Insight Partners) with the goal of optimizing asset value propositions COMMERCIAL PORTFOLIO DEVELOPMENT Function: Team members were the commercial representatives to the Core Project Teams (CPTs) for assets from pre-clinical through mid-Phase 3 Role: Implement vision to establish earlier, more impactful input to pipeline - Ensure team members, as part of the CPTs, deliver pipeline assets positioned for commercial success based on critical insights - Market development, life-cycle planning & pre-launch activity through mid-Phase 3 - Lead commercial assessment for business development opportunities Key achievements: - Successfully concluded partnership on Ph3 asset - Recognition for earlier, more structured, and strategic input to early development assets CUSTOMER INSIGHTS Function: Primary Mkt Res, Business Analysis, Competitive Intel, & Insight Partner groups supporting Global Marketing to discover deep market and brand insights, and ensure those learnings go into fact-based decisions for the brands and therapy area strategies Responsibility: Implement vision of increased cross-functional collaboration & partnership - Ensure discovery of actionable market insights by identifying unmet needs & white-spaces, characterizing market opportunities as the basis for critical decision-making - Deliver deeper insight critical to launch brand success via KPI tracking, real-time data analysis, challenging & validating hypotheses Key achievements: - Implement Insight Partner-led annual Situational Analysis process leading into Brand Plan cycle - Successful transition of “Insight Partner” role to strategic, qualitative experts that proactively drove deeper insight generation - Successful redeployment of numerous individuals within the group to more optimal roles, with resulting excellent feedback for those individuals in their new roles Show less



Pfizer

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Director, External Opportunities & Alliance Management

  • Jun 2011 - Dec 2012

  Renal & Rare Disease Therapy AreasFunction: Commercial lead for identification & assessment of BD opportunitiesResponsibility:- Identify high-potential assets / companies for licensing, partnership, & acquisition- Commercial assessment of opportunity, including forecast and P&L development- Member of Rare Disease BD leadership team responsible for endorsing business development strategy that aligns with the therapeutic area’s overall business strategy (including identification of gaps in the portfolio & potential complimentary assets)Key achievement: - In-license of a Phase 2 asset for the hematology disease area, where I drove the commercial assessment, including identifying physician/ payer research needs, forecast / P&L creation, & presentation to governance resulting in endorsement. It was the only endorsed in-license/acquisition completed by the Specialty Care unit during my tenor Show less

• Director, Commercial Planning

  • Mar 2010 - Jun 2011

  Hematology, Renal, & Transplant Therapy AreasFunction: Partner with R&D to deliver commercially attractive pipeline assets to the Specialty Care Business Unit at the point of “proof-of-concept”Responsibility:- Direct commercial development for pre-Proof of Concept (POC) compounds; develop minimally acceptable clinical profiles for R&D, providing target needed to achieve to be brought into the business unit for further development- Lead commercial assessment of business development opportunities, including potential revenues, expenses, and strategic portfolio fit - Support disease area leads in therapeutic area strategy development- Managed $1M budget covering strategy development, market research, and business development needs within therapeutic areas- Drove therapy area input to cross-BU prioritization; competitive assessment of key disease states, including potential commercialization costs and revenuesKey achievements:- Endorsement & implementation of Renal and Transplant disease area strategies- Achieved alignment & endorsement for proof-of-concept studies for assets in polycystic kidney disease (PDK) and chronic kidney disease (CKD) Show less



Pfizer

• United States
• Pharmaceutical Manufacturing
• 700 & Above Employee

• Product Director, Pristiq Marketing, Business Management

  • 2008 - 2010

  Function: Lead the commercial strategic direction of the brandResponsibility:- Direct commercial lifecycle strategic considerations within major depressive disorder (MDD), as well as continued development of vasomotor symptoms (VMS) indication- Solicit thought leader expertise for guidance in brand strategy development- Provide commercial insight to Global Labeling teamKey achievements: - Annual endorsement for life-cycle strategy, which included additional investment for VMS indication, as well as stopping pain programs- Led cross-functional task-force in mid-2008 to recommend unique opportunities to drive brand revenue / profit in a 3-yr horizon, which were endorsed & implemented Show less

• Product Director, Pristiq Marketing, Payer

  • 2006 - 2008

  Function: Direct Payer strategy & tactical development for May ‘08 US launchResponsibility:- Hired & managed agency of record, planning of market research & advisory boards- Led development of launch US pricing & contracting platform for brand; collaborated with Health Outcomes to develop models relevant to critical payer needs- Led effort to model sales representative – physician – patient – pharmacy interactions to optimize co-pay assistance program- Incorporation of field insights to ensure brand strategy would be successfully implemented through account managersKey achievements: - Endorsement of overall payer strategy/ positioning platform- Endorsement of US pricing strategy, which led to >60% Tier 2 access within 1yr Show less

• Director, Global Strategic Forecasting, Pharma BU

  • 1999 - 2006

  Function: Responsible for gaining organizational alignment on long-term, global strategic forecasts for the Pharma Business Unit, which exceeded $7.5 Billion in Global Net RevenueResponsibility:- Management of two direct reports (first managerial role)- Modeled therapeutic marketplace for long-range forecasts of in-line, pipeline, and licensing opportunities within CNS, GI, and Anti-infectives. Incorporated risk-analysis assessment (Crystal Ball, @Risk software) of long-range uncertainty.- Created new company standard for assessment of product reimbursement by developing method of payment (MOP) forecast to more accurately estimate & track the impact of discounts across Commercial (Managed Care), Medicaid, & Medicare- Championed new opportunities based on analysis of complex market dynamics, including combination usage, interaction of franchise products, and impact of over-the-counter (OTC) products on Rx therapeutic areasKey achievements: - Within 5% of revenue forecast for full-year 2005- Created innovative new assessment methods, such as a new company standard to assess product reimbursement by method of payment (MOP) to more accurately track the impact of discounts across Commercial (Managed Care), Medicaid, & Medicare- Individual Awards: President’s Golden Circle Award (2003); President’s Leadership Award (2001, 2005); Team Awards: President’s Achieving Excellence (2003, 2005)- In July 2003, promoted from Manager to Director (with direct reports) Show less



Federal Reserve Bank of Philadelphia

• United States
• Financial Services
• 500 - 600 Employee

• Senior Financial Reports Analyst

  • Jul 1994 - Apr 1999

  The FRB of Philadelphia helps formulate and implement monetary policy, supervises banks & holding companies, and provides financial services to depository institutions and the federal government. It employed roughly 1,200 individuals in 1999. Sr Financial Reports Analyst, Financial Statistics Division Function: Statistical analysis of complex financial reports to ensure compliance of financial institutions to regulatory mandates, as well as early identification of changing market dynamics Responsibility: - Created new tools for the analysis and estimation (forecasting) of data - Worked with Board of Governors to resolve reporting issues - Trained and reviewed work of new hires Key Achievements: - New statistical analyses and triangulation methodology standards to better predict outliers (ie, institutions reporting incorrectly, or catching new market dynamics) Show less